コロンビア特別区における転移性癌の臨床試験
コロンビア特別区内の拠点で、転移性癌に関する24件の研究が参加者を募集しています。
コロンビア特別区内の都市
公式研究テキスト（英語）
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Georgetown University Hospital, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Georgetown University, Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- The George Washington Medical facility Associates, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/24更新 · NCT05118789A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- MedStar Washington Hospital Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- MedStar Washington Hospital Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06863272CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Clinical Study Site, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07335497A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Washington D.C.
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Washington D.C.
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/08/18更新 · NCT06792695FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Washington D.C.
被験者募集中第3相
18歳以上 · 女性 · 2026/07/29更新 · NCT07044336Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- George Washington University, Washington D.C.
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/07/14更新 · NCT05533697(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
- MedStar Washington Hospital Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/16更新 · NCT05208047A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT05384626Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/23更新 · NCT02333604A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- The George Washington University, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
被験者募集中第2/3相
18歳以上 · 男性 · 2026/04/08更新 · NCT04787744A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Georgetown University Medical Center, Washington D.C.
被験者募集中第2/3相
全年齢 · 全性別 · 2026/04/02更新 · NCT06581406A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/25更新 · NCT06521554VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The George Washington University Cancer Center (site 212), Washington D.C.
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。